BACKGROUND: Elevated antibodies against Chlamydia pneumoniae have been
associated with coronary artery disease. In patients undergoing percutaneous coronary …

Background: The aim of this study was to establish whether Chlamydia pneumoniae is
implicated in the development of restenosis in patients with coronary heart disease (CHD) …

Chlamydia pneumoniae is frequently found in atherosclerotic lesions, and high titers of
specific antibodies are associated with increased risk for acute myocardial infarction …

Summary Background Vascular infection with Chlamydia pneumoniae might boost
inflammatory responses that play a pivotal part in neointima formation, which is the main …

Objectives: The potential role of common infectious agents in the pathogenesis and
progression of atherosclerosis has been studied increasingly over the last decade. The …

This study was done to evaluate whether anti-Chlamydia pneumoniae seropositivity can be
a predictor of restenosis after coronary intervention. Recent studies indicate that latent …

Background: Infection with Chlamydia pneumoniae may be involved in atherosclerosis.
Neointima proliferation after percutaneous coronary intervention (PCI) could be aggravated …

Aims: Since infection of endothelial or smooth muscle cells with Chlamydia pneumoniae
increased expression of tissue factor and plasminogen activator inhibitor I (PAI-1), C …

Background—It has been suggested that infection with Chlamydia pneumoniae (CPn) can
trigger inflammatory mechanisms that may in turn impair vascular endothelial function. The …

Purpose Two mega trials have raised the question as to whether the hypothesis that
infection plays a role in atherosclerosis is still relevant. This controlled preliminary trial …